Senior Clinical Research Fellow in Translational Myeloma Research at University of Oxford

Applications are invited for the position of Senior Clinical Research Fellow in Translational Myeloma Research. This is an exciting opportunity to join a team of cutting-edge researchers and clinicians at Oxford Translational Myeloma centre (OTMC) based at the Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford.

OTMC is set up to conduct and lead Multiple Myeloma (MM) research to transform quality, outcome, and cost of patient care. Our main goal is to cure or significantly improve long-term survival/remission by applying a personalised care strategy. The fellow will forge closer working of the OTMC laboratories at the Botnar Research Centre with the Haemato oncology Diagnostic Service lab at the John Radcliffe Hospital and the clinical service at Churchill Hospital.

As a Senior Clinical Research Fellow in Translational Myeloma Research you will be actively involved in research and clinical activities within OTMC. You will develop clinical research questions in areas related to the group’s area of expertise. You will contribute to the dissemination of scientific results by means of writing papers for publication, presenting orally and in poster form at national and international meetings. You will be actively involved in clinical duties such as attending myeloma clinics, participate in the development of the myeloma and other plasma cell dyscrasia service including protocol and pathway development and review, participate in the monthly service operational and governance meeting.

You will hold a PhD or MD with focus on haemato-oncological disorders. You will have a full and specialist registration (and a licence to practise) with the General Medical Council (GMC) and be a holder of a Certificate of Completion of Training (CCT), or be within six months of award of CCT by date of interview. Experience of clinical haematology and working on clinical trials which are GCP-compliant, and of the process of obtaining and maintaining regulatory and ethics approvals, experience in leading and/or having major contributions to haemato-oncological studies and publications and understanding of clinical governance as applied to delivery of clinical services are essential. Track record of grants awarded in the field of haematological malignancy, basic understanding of healthcare funding streams and commissioning and experience in developing ethically approved clinical protocols are desirable.

This is a full-time fixed-term appointment for 5 years.

The closing date for this position is 12 noon on 14/07/2023. You will be required to upload a CV and supporting statement as part of your online application